S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q4 2023

BVF Partners

Periodo: Q4 2023 · Depositato: 2024-02-14
Vedi su SEC EDGAR
AUM
$4.00B
Valore totale del portafoglio
Posizioni
70
Titoli dichiarati
Prima Posizione
MLTX
32.9% $1.31B
Var. Trimestrali
+7 / -6
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2024-02-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
MLTXMOONLAKE IMMUNOTHERAPEUTICS$1.31B32.87%$59.55$18.95-68.2%
32.9%
RVMDREVOLUTION MEDICINES INC$171.5M4.29%$28.23$189.24+570.4%
4.3%
AXSMAXSOME THERAPEUTICS INC$157.7M3.95%$77.06$244.31+217.0%
4.0%
PTGXPROTAGONIST THERAPEUTICS INC$131.7M3.30%$23.42$131.62+462.0%
3.3%
KYMRKYMERA THERAPEUTICS INC$131.4M3.29%$25.35$113.51+347.8%
3.3%
MIRMMIRUM PHARMACEUTICALS INC$129.0M3.23%$30.02$125.59+318.4%
3.2%
OLMAOLEMA PHARMACEUTICALS INC$128.2M3.21%$13.73$12.64-7.9%
3.2%
IONSIONIS PHARMACEUTICALS INC$122.9M3.07%$52.87$81.80+54.7%
3.1%
KURAKURA ONCOLOGY INC$106.0M2.65%$15.36$11.10-27.7%
2.6%
FDMT4D MOLECULAR THERAPEUTICS IN$81.2M2.03%$21.25$13.00-38.8%
2.0%
LKFTGALAPAGOS NV$77.8M1.95%$41.34$30.39-26.5%
1.9%
MRUSMERUS N V$75.7M1.89%
1.9%
RPTXREPARE THERAPEUTICS INC$75.4M1.89%
1.9%
ACIUAC IMMUNE SA$72.9M1.82%$4.69$2.51-46.5%
1.8%
CNTACENTESSA PHARMACEUTICALS PLC$69.8M1.75%$8.03$40.50+404.4%
1.8%
XOMAXOMA CORP DEL$67.2M1.68%$20.89$43.00+105.8%
1.7%
IDYAIDEAYA BIOSCIENCES INC$61.5M1.54%$35.22$37.65+6.9%
1.5%
ZYMEZYMEWORKS INC$61.0M1.53%$10.38$26.31+153.5%
1.5%
GHRSGH RESEARCH PLC$60.3M1.51%$5.35$27.01+404.9%
1.5%
EPIXESSA PHARMA INC$57.7M1.45%
1.4%
JANXJANUX THERAPEUTICS INC$49.1M1.23%$11.02$15.54+41.0%
1.2%
THRDTHIRD HARMONIC BIO INC$47.9M1.20%
1.2%
ETNB89BIO INC$45.2M1.13%
1.1%
RLAYRELAY THERAPEUTICS INC$43.7M1.09%$11.85$18.65+57.4%
1.1%
XENEXENON PHARMACEUTICALS INC$41.0M1.03%$44.91$60.96+35.7%
1.0%
SNDXSYNDAX PHARMACEUTICALS INC$40.5M1.01%$21.86$21.82-0.2%
1.0%
TYRATYRA BIOSCIENCES INC$37.9M0.95%$14.04$30.62+118.1%
0.9%
LXRXLEXICON PHARMACEUTICALS INC$37.4M0.94%$1.59$2.32+45.9%
0.9%
GPCRSTRUCTURE THERAPEUTICS INC$33.1M0.83%$40.39$53.45+32.3%
0.8%
CGEMCULLINAN ONCOLOGY INC$32.6M0.82%$10.59$17.63+66.5%
0.8%

Attività Trimestre su Trimestre

Q4 2023 vs. Q3 2023

Nuove Posizioni (7)

TickerEmittenteNozionaleDal Deposito
SNDXSYNDAX PHARMACEUTICALS INC$40.5M-0.2%
ANNXANNEXON INC$31.8M
ENGNENGENE HOLDINGS INC$20.8M
SYRESPYRE THERAPEUTICS INC$14.8M
VTGNVISTAGEN THERAPEUTICS INC$10.3M
SABSSAB BIOTHERAPEUTICS INC$6.3M
ENGNWENGENE HOLDINGS INC$0.8M

Posizioni Chiuse (6)

TickerEmittenteNozionale
PNTPOINT BIOPHARMA GLOBAL INC$70.5M
ACRSACLARIS THERAPEUTICS INC$48.4M
REPLREPLIMUNE GROUP INC$36.7M
JSPRXXXXJASPER THERAPEUTICS INC$6.9M
IMUXIMMUNIC INC$1.7M
BNOXBIONOMICS LIMITED$0.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ETNB89BIO INC$16.7M+119.2%
ACIUAC IMMUNE SA$51.7M+96.2%-46.5%
RLAYRELAY THERAPEUTICS INC$23.8M+67.8%+57.4%
IKNAIKENA ONCOLOGY INC$-4.3M+50.5%
RVMDREVOLUTION MEDICINES INC$61.3M+50.2%+570.4%
RPTXREPARE THERAPEUTICS INC$-24.7M+24.6%
LXRXLEXICON PHARMACEUTICALS INC$15.6M+22.2%+45.9%
GHRSGH RESEARCH PLC$-32.9M+12.1%+404.9%

Ridotte (7)

TickerEmittenteNozionaleVar. AzioniDal Deposito
IDYAIDEAYA BIOSCIENCES INC$-81.0M-67.3%+6.9%
GPCRSTRUCTURE THERAPEUTICS INC$-55.1M-53.5%+32.3%
XENEXENON PHARMACEUTICALS INC$-21.4M-51.3%+35.7%
IONSIONIS PHARMACEUTICALS INC$-58.8M-39.4%+54.7%
UNCYUNICYCIVE THERAPEUTICS INC$-1.1M-37.9%
AXSMAXSOME THERAPEUTICS INC$8.7M-7.0%+217.0%
CNTACENTESSA PHARMACEUTICALS PLC$10.9M-3.6%+404.4%
Torna agli Hedge Fund